Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study. [electronic resource]
Producer: 20120313Description: R94 p. digitalISSN:- 1478-6362
- Adalimumab
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Etanercept
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin G -- administration & dosage
- Infliximab
- Longitudinal Studies
- Male
- Middle Aged
- Predictive Value of Tests
- Prospective Studies
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Severity of Illness Index
- Spondylitis, Ankylosing -- drug therapy
- Substance Withdrawal Syndrome -- diagnosis
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.